Preemptive mechanical ventilation can block progressive acute lung injury

Area of Science:

• Critical Care Medicine
• Pulmonology
• Respiratory Physiology

Background:

• Mortality from acute respiratory distress syndrome (ARDS) remains high, particularly in at-risk populations.
• Current treatments for fulminant ARDS are primarily supportive, highlighting a need for preventative strategies.
• ARDS is a progressive condition with a critical early window for intervention.

Purpose of the Study:

• To review clinical and basic science studies on ARDS treatment resistance.
• To evaluate the impact of early, protective mechanical ventilation on ARDS prevention.
• To assess Airway Pressure Release Ventilation (APRV) as a prophylactic measure for ARDS.

Main Methods:

• Systematic review of clinical studies on ARDS treatment.
• Examination of basic science and clinical research on early mechanical ventilation.
• Analysis of studies investigating Airway Pressure Release Ventilation (APRV) in preventing acute lung injury (ALI) and ARDS.

Main Results:

• Fulminant ARDS is largely resistant to pharmacologic treatments and conventional ventilation.
• Early initiation of protective mechanical ventilation before lung injury onset can prevent ARDS progression.
• APRV demonstrated efficacy in blocking progressive ALI and preventing its advancement to ARDS.

Conclusions:

• Preventing ARDS before its clinical manifestation is key, given its progressive nature and high mortality.
• Early protective mechanical ventilation, particularly APRV, offers significant prophylactic benefits.
• APRV may be the preferred prophylactic treatment for preventing ARDS in susceptible patients.